The Glimpse Group Signs Mid 6-Figure Contract with Global Pharma
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 25 2026
0mins
Should l Buy GGRP?
The Glimpse Group's Sector 5 Digital entered into a mid 6-figure dollar follow-on contract with a global pharmaceutical company for a 3D based anatomy training platform.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GGRP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GGRP
Wall Street analysts forecast GGRP stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 0.605
Low
Averages
High
Current: 0.605
Low
Averages
High
No data
About GGRP
The Glimpse Group, Inc. is a diversified immersive technology platform company, providing enterprise-focused virtual reality, augmented reality and spatial computing software and services. The Company is focused on providing immersive technology solutions software and services that are primarily driven by spatial computing, cloud and artificial intelligence (AI), which it refers to as spatial core. The Company's operating entities are located primarily in the United States, with a development and modeling center in Turkey. It targets an array of industry verticals, including but not limited to: corporate training, education, healthcare, government & defense, branding/marketing/advertising, retail, financial services, food & hospitality, architecture/engineering/construction, corporate events and presentations and social VR support groups and therapy. It is focused primarily on the business-to-business and business-to-business-to-consumer segments industry, and it is hardware agnostic.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
